SSIEM 2022 poster: Demographics and baseline characteristics of patients with cerebral palsy of unknown aetiology in the REVEAL-CP observational study
This poster, presented at SSIEM 2022, provides an overview of the REVEAL-CP study, which has been designed to determine the prevalence of aromatic L-amino acid decarboxylase (AADC) deficiency
Learn more about the diagnostic procedures for AADC deficiency, and how these can be used to differentially diagnose AADC deficiency from more common conditions such as cerebral palsy (CP) Explore how 3- O-methyldopa levels could help to facilitate early and accurate diagnosis of AADC deficiency Review the baseline and demographic data for patients with CP-like symptoms of unknown etiology
This poster was developed and funded by PTC Therapeutics for SSIEM 2022. It is not part of the official program at SSIEM 2022.
Register now to unlock the content
Register now to access the content on this page
If not, register below
MED-ALL-AADC-2200242 | September 2022
Sign in or register to access exclusive content on this site
Close Register here to access the content on the site MED-ALL-CORP-2200029 | December 2022
You are now leaving MEDhub, a website provided by PTC Therapeutics. This link will take you to a website to which our
Privacy Statement and our Terms and Conditions do not apply.
MED-ALL-CORP-2200029 | December 2022
Close COMING SOON
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available,